- RecruitingPHASE3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
This study looks at a new drug, zasocitinib, for adults with psoriatic arthritis. It aims to see how well it works compared to a dummy drug. We're interested in people who have or haven't tried certain other treatments before.
For: Psoriatic ArthritisUnited States · Argentina · Australia - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects with Moderate-to-Severe Plaque Psoriasis
This study is testing a new drug, TAK-279, for people with moderate to severe plaque psoriasis. We want to see if it's safe and effective compared to a known treatment (Otezla) and a dummy pill (placebo) to help clear up skin patches.
For: Moderate to Severe Plaque PsoriasisPoland · Italy · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study With a Randomized Withdrawal and Retreatment Period to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis
This study is testing a new medicine, ZASOCITINIB (also called TAK-279), for people with moderate to severe plaque psoriasis. It compares the new medicine to existing treatments like Otezla and a dummy pill (placebo) to see how well it works and if it's safe.
For: Moderate to Severe Plaque PsoriasisGermany · Poland · Latvia - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Multicenter, Double-Blind Trial to Evaluate the Efficacy, Safety, and Tolerability of Zasocitinib (TAK-279) Compared to Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis
This study is testing a new medicine, Zasocitinib (TAK-279), for people with moderate to severe plaque psoriasis. It compares it to an existing medicine, Deucravacitinib (SOTYKTU), and a dummy pill to see how well it works, if it's safe, and how people tolerate it.
For: Moderate to Severe Plaque PsoriasisCzechia · France · Bulgaria - AuthorisedTherapeutic exploratory (Phase II)
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa
This study is testing a new medication called Zasocitinib for people with moderate to severe Hidradenitis Suppurativa (HS). Researchers want to see if it helps reduce HS symptoms and if it's safe. It's a 'Phase 2' study, meaning they are still exploring its effectiveness and safety.
For: Hidradenitis SuppurativaFrance · Poland · Netherlands